Trials / Completed
CompletedNCT06241066
The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 359 (actual)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Retrospective analysis of the presence and maturity of tertiary lymphoid structures in pathological sections of patients with esophageal squamous cell carcinoma after surgical treatment. Pay attention to the overall survival and disease free survival of these esophageal squamous cell carcinoma patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no-Intervention | no-Intervention |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
- First posted
- 2024-02-05
- Last updated
- 2024-02-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06241066. Inclusion in this directory is not an endorsement.